ACAD · Forms 3, 4, 5

Insider trades at ACADIA PHARMACEUTICALS INC

2 insiders sold $1M of ACADIA PHARMACEUTICALS INC stock on the open market in the last 90 days.

Every Form 3, 4 and 5 filed for ACADIA PHARMACEUTICALS INC (ACAD) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.

Insider trades in the last 90 days

DateInsiderRoleTransactionSharesPriceValueFiling
Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICEROption exercise14,292$17.84$255KForm 4
Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICERSell5,000$29.00$145KForm 4
Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICERSell9,292$29.34$273KForm 4
Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICEROption exercise5,849$17.84$104KForm 4
Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICERSell5,849$29.00$170KForm 4
Elizabeth H.Z. ThompsonEVP, Head of Research & DevSell16,508$26.13$431KForm 4
Elizabeth H.Z. ThompsonEVP, Head of Research & DevSell50$26.17$1KForm 4
Elizabeth H.Z. ThompsonEVP, Head of Research & DevOption exercise32,272Form 4

Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.